You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.
Show More
CA116-003
Medable Inc.
Free
5+
downloads
About CA116-003
CA116-003 Screenshots
